Summary
Previous studies have shown that the thiol redox, as measured by the ratio of free/bound cyst(e)ine in unaffected individuals, remains relatively constant. In severe homocystinuria (HCU) where cyst(e)ine moieties are significantly reduced, this redox is only restored when homocyst(e)ine moieties are also taken into account. This appears to stem from an increase in the free/bound homocyst(e)ine ratio with free homocystine acting as a surrogate for free cystine. We examined these ratios in 47 patients (two with a cobalamin C defect, two with methylenetetrahydrofolate reductase deficiency, 16 with pyridoxine-responsive HCU and 27 with pyridoxine-nonresponsive HCU). Comparing free/bound homocyst(e)ine ratios to the total cysteine concentration indicates a relative increase of free homocystine as total cysteine concentrations fall below 170 μmol/L. This provides a rationale and treatment algorithm for cyst(e)ine supplementation in homocystinuria.
Similar content being viewed by others
Abbreviations
- CblC:
-
cobalamin C
- CBS:
-
cystathionine β-synthase (EC 4.2.1.22)
- DTT:
-
dithiothreitol
- HCU:
-
homocystinuria (from CBS deficiency, OMIM 236200 from MTHFR deficiency, OMIM 236250, from CblC defect, OMIM 277400)
- MDS:
-
cysteine–homocysteine mixed disulfide
- MTHFR:
-
methylenetetrahydrofolate reductase (EC 1.1.1.68)
- tCys:
-
total reduced cysteine accrued from free cystine, mixed disulfide and protein-bound forms
- tHcy:
-
total reduced homocysteine accrued from free homocystine, mixed disulfide and protein-bound forms
References
Briddon A (1998) Total plasma homocysteine as part of the routine aminogram by ion-exchange chromatography. Amino Acids 15: 235–239.
Briddon A (2003) Observations on albumin-aminothiol binding. J Inherit Metab Dis 26(Supplement 1): 51.
Fowler B (1997) Disorders of homocysteine metabolism. J Inherit Metab Dis 20: 731–741.
Hargreaves IP, Lee PJ, Briddon A (2002) Homocysteine and cysteine-albumin binding in homocystinuria: assessment of cysteine status and implications for glutathione synthesis? Amino Acids 22: 109–118.
Moat SJ, Bonham JR, Tanner MS, Allen JC, Powers HJ (1995) Recommended approaches for the laboratory measurement of homocysteine in the diagnosis and monitoring of patients with hyperhomocysteinaemia. Ann Clin Biochem 36: 372–379.
Orendac M, Zeman J, Stabler SP, et al (2003) Homocystinuria due to cystathionine β-synthase deficiency: novel biochemical findings and treatment efficacy. J Inherit Metab Dis 26: 761–773.
Togawa T, Sengupta S, Chen H, et al (2000) Mechanisms for the formation of protein-bound homocysteine in human plasma. Biochem Biophys Res Commun 277: 668–674.
Ueland PM, Mansoor MA, Guttormsen AB, et al (1996) Reduced, oxidised and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status—a possible element of the extracellular antioxidant defence mechanism. J Nutr 126: 1281S–1284S.
Wilcken DEL, Wilcken B (1997) The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis 20: 295–300.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Brian Fowler
Competing interests: None declared
Rights and permissions
About this article
Cite this article
Lee, P.J., Briddon, A. A rationale for cystine supplementation in severe homocystinuria. J Inherit Metab Dis 30, 35–38 (2007). https://doi.org/10.1007/s10545-006-0452-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-006-0452-3